Injury and Illness Surveillance During the 2019 Department of Defense Warrior Games

Authors

  • Robert Lystrup United States Air Force
  • Chad Hulsopple National Capital Consortium Sports Medicine Fellowship Program
  • Jeffrey Leggit Uniformed Services University School of Medicine
  • Jeremiah "Jake" Mills United States Navy
  • Timothy Hansen United States Army

Keywords:

Wounded warriors, Department of Defense Warrior Games, injuries, disabilities

Abstract

The 2019 Department of Defense Warrior Games is an adaptive, multi-sport event for wounded service members from the United States and international partners. The purpose of this study was to describe the injury/ illness outcomes of the 2019 DoD Warrior Games. Using a descriptive epidemiological study design, 295 wounded warrior (WW) athletes were followed over the 15-day course of the Warrior Games. Treatment team members recorded all encounters, injury or illness characterization, and the treatment provided. Results from June 16 to June 30, 2019 found that 107 medical encounters were recorded and entered into a database. Injuries accounted for 64% and illnesses 36% of encounters. Athlete days were calculated by multiplying the number of athletes by the total number of days for the warrior games. Thus the total number of athlete days was 295 athletes x 15 days = 4,425 athlete days. The incident rate of injuries was 15.6 per 1,000 athlete days. The incident rate of illness was 8.6 per 1000 athlete days. The most common injury was a low back strain, and the most common illness was heat exhaustion. Integrative medicine treatments such as acupuncture, osteopathic manipulative therapy, massage, and Gua Sha (a form of skin scraping) were the most common treatment modalities (26%). This event is the second time a surveillance system has been used to track injury patterns and the associated medical utilization at the Department of Defense Warrior Games. This surveillance data provides another useful benchmark in planning for future events.

Downloads

Published

2022-09-03

Issue

Vol. 36 No. 3 (2022)

Section

Feature Articles

License

Sagamore Publishing LLC (hereinafter the “Copyright Owner”)

Journal Publishing Copyright Agreement for Authors

PLEASE REVIEW OUR POLICIES AND THE PUBLISHING AGREEMENT, AND INDICATE YOUR ACCEPTANCE OF THE TERMS BY CHECKING THE ‘AGREE TO THE TERMS OF THIS COPYRIGHT NOTICE’ CHECKBOX BELOW.

I understand that by submitting an article to PALAESTRA, I am granting the copyright to the article submitted for consideration for publication in PALAESTRA to the Copyright Owner. If after consideration of the Editor of the PALAESTRA, the article is not accepted for publication, all copyright covered under this agreement will be automatically returned to the Author(s).

THE PUBLISHING AGREEMENT

Assignment of Copyright


I hereby assign to the Copyright Owner the copyright in the manuscript I am submitting in this online procedure and any tables, illustrations or other material submitted for publication as part of the manuscript in all forms and media (whether now known or later developed), throughout the world, in all languages, for the full term of copyright, effective when the article is accepted for publication.

Reversion of Rights

Articles may sometimes be accepted for publication but later be rejected in the publication process, even in some cases after public posting in “Articles in Press” form, in which case all rights will revert to the Author.

Retention of Rights for Scholarly Purposes

I understand that I retain or am hereby granted the Retained Rights. The Retained Rights include the right to use the Preprint, Accepted Manuscript, and the Published Journal Article for Personal Use and Internal Institutional Use.

All journal material is under a 12 month embargo. Authors who would like to have their articles available as open access should contact Sagamore-Venture for further information.

In the case of the Accepted Manuscript and the Published Journal Article, the Retained Rights exclude Commercial Use, other than use by the author in a subsequent compilation of the author’s works or to extend the Article to book length form or re-use by the author of portions or excerpts in other works.

Published Journal Article: the author may share a link to the formal publication through the relevant DOI.

Author Representations

  • The Article I have submitted to the journal for review is original, has been written by the stated author(s) and has not been published elsewhere. 

  • The Article was not submitted for review to another journal while under review by this journal and will not be submitted to any other journal. 

  • The Article contains no libelous or other unlawful statements and does not contain any materials that violate any personal or proprietary rights of any other person or entity.
  • I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in the Article.
  • If the Article was prepared jointly with other authors, I have informed the co-author(s) of the terms of this Journal Publishing Agreement and that I am signing on their behalf as their agent, and I am authorized to do so.